Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2025 | 799 | 1.550 |
Why?
|
| Nephritis, Interstitial | 2 | 2023 | 39 | 1.510 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 113 | 0.770 |
Why?
|
| Electrolytes | 1 | 2022 | 57 | 0.760 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 249 | 0.630 |
Why?
|
| Kidney Diseases | 1 | 2022 | 482 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1357 | 0.420 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 2 | 2025 | 18 | 0.420 |
Why?
|
| Ceramides | 1 | 2013 | 46 | 0.400 |
Why?
|
| Agrochemicals | 2 | 2023 | 13 | 0.400 |
Why?
|
| Reperfusion Injury | 2 | 2025 | 108 | 0.380 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 90 | 0.370 |
Why?
|
| Kidney Tubules | 2 | 2025 | 77 | 0.280 |
Why?
|
| Acute Kidney Injury | 2 | 2025 | 664 | 0.240 |
Why?
|
| Kidney | 2 | 2023 | 1283 | 0.230 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2025 | 134 | 0.230 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 60 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 74 | 0.200 |
Why?
|
| Mice | 8 | 2025 | 17686 | 0.200 |
Why?
|
| Paraquat | 1 | 2022 | 14 | 0.190 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.190 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 40 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 92 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 118 | 0.180 |
Why?
|
| Peritoneal Dialysis | 1 | 2023 | 129 | 0.170 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 31 | 0.170 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 33 | 0.160 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 456 | 0.160 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 25 | 0.160 |
Why?
|
| Animals | 8 | 2025 | 33197 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1206 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4513 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2020 | 452 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 500 | 0.130 |
Why?
|
| Mitochondria | 3 | 2022 | 729 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2024 | 936 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 493 | 0.120 |
Why?
|
| Sphingosine | 1 | 2013 | 20 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 54 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3683 | 0.100 |
Why?
|
| Sphingolipids | 1 | 2013 | 33 | 0.100 |
Why?
|
| Culture Media | 1 | 2013 | 173 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 127335 | 0.100 |
Why?
|
| Male | 6 | 2025 | 62795 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 2586 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 56 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2013 | 351 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1162 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2011 | 98 | 0.080 |
Why?
|
| Female | 5 | 2024 | 68638 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 405 | 0.080 |
Why?
|
| Risk Factors | 1 | 2023 | 10612 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2025 | 3718 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2011 | 665 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3502 | 0.060 |
Why?
|
| Child | 2 | 2023 | 25299 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17068 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 973 | 0.060 |
Why?
|
| Epithelium | 1 | 2025 | 340 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1759 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 79 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 827 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2023 | 47 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 226 | 0.050 |
Why?
|
| Alanine | 1 | 2023 | 162 | 0.050 |
Why?
|
| Leucine | 1 | 2022 | 258 | 0.040 |
Why?
|
| Superoxides | 1 | 2021 | 129 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 400 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2022 | 338 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2120 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 74 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 770 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 314 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 477 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1421 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2025 | 4485 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 1128 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 610 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1216 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 497 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 604 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 597 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2311 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 989 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2011 | 75 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 604 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3235 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 3589 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 330 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 217 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4446 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 477 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3074 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2759 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 30544 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 20433 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 27818 | 0.010 |
Why?
|